PTPN11 and viral infectious disease: The allosteric small molecular inhibitor of SHP2, SHP099, was employed to treat A549 cells prior to virus infection, and it was observed that the expressions of PD-L1 and NP were inhibited by SHP099 treatment (Figure 7 and Figure 8).